These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 33162808)
1. CSN6 promotes the cell migration of breast cancer cells by positively regulating Snail1 stability. Mou J; Wei L; Liang J; Du W; Pei D Int J Med Sci; 2020; 17(17):2809-2818. PubMed ID: 33162808 [No Abstract] [Full Text] [Related]
2. CSN6 controls the proliferation and metastasis of glioblastoma by CHIP-mediated degradation of EGFR. Hou J; Deng Q; Zhou J; Zou J; Zhang Y; Tan P; Zhang W; Cui H Oncogene; 2017 Feb; 36(8):1134-1144. PubMed ID: 27546621 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of CSN6 promotes the epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma. Xu M; Zhen L; Lin L; Wu K; Wang Y; Cai X Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):340-348. PubMed ID: 31422034 [TBL] [Abstract][Full Text] [Related]
4. CSN6 Promotes the Migration and Invasion of Cervical Cancer Cells by Inhibiting Autophagic Degradation of Cathepsin L. Mao Z; Sang MM; Chen C; Zhu WT; Gong YS; Pei DS Int J Biol Sci; 2019; 15(6):1310-1324. PubMed ID: 31223289 [TBL] [Abstract][Full Text] [Related]
5. CSN6 inhibition suppresses pancreatic adenocarcinoma metastasis via destabilizing the c-Fos protein. Ma F; Wang H; Liu K; Wang Z; Chen S Exp Cell Res; 2020 Jun; 391(1):112004. PubMed ID: 32289284 [TBL] [Abstract][Full Text] [Related]
6. CSN6 promotes melanoma proliferation and metastasis by controlling the UBR5-mediated ubiquitination and degradation of CDK9. Zhang Y; Hou J; Shi S; Du J; Liu Y; Huang P; Li Q; Liu L; Hu H; Ji Y; Guo L; Shi Y; Liu Y; Cui H Cell Death Dis; 2021 Jan; 12(1):118. PubMed ID: 33483464 [TBL] [Abstract][Full Text] [Related]
7. Subunit 6 of the COP9 signalosome promotes tumorigenesis in mice through stabilization of MDM2 and is upregulated in human cancers. Zhao R; Yeung SC; Chen J; Iwakuma T; Su CH; Chen B; Qu C; Zhang F; Chen YT; Lin YL; Lee DF; Jin F; Zhu R; Shaikenov T; Sarbassov D; Sahin A; Wang H; Wang H; Lai CC; Tsai FJ; Lozano G; Lee MH J Clin Invest; 2011 Mar; 121(3):851-65. PubMed ID: 21317535 [TBL] [Abstract][Full Text] [Related]
8. The Emerging Role of CSN6 in Biological Behavior and Cancer Progress. Mao Z; Chen C; Pei DS Anticancer Agents Med Chem; 2019; 19(10):1198-1204. PubMed ID: 30961513 [TBL] [Abstract][Full Text] [Related]
9. Regulating the stability and localization of CDK inhibitor p27(Kip1) via CSN6-COP1 axis. Choi HH; Guma S; Fang L; Phan L; Ivan C; Baggerly K; Sood A; Lee MH Cell Cycle; 2015; 14(14):2265-73. PubMed ID: 25945542 [TBL] [Abstract][Full Text] [Related]
10. Downregulation of CSN6 attenuates papillary thyroid carcinoma progression by reducing Wnt/β-catenin signaling and sensitizes cancer cells to FH535 therapy. Wen D; Liao T; Ma B; Qu N; Shi RL; Lu ZW; Wang YL; Wei WJ; Ji QH Cancer Med; 2018 Feb; 7(2):285-296. PubMed ID: 29341469 [TBL] [Abstract][Full Text] [Related]
11. CSN6 positively regulates c-Jun in a MEKK1-dependent manner. Shin J; Phan L; Chen J; Lu Z; Lee MH Cell Cycle; 2015; 14(19):3079-87. PubMed ID: 26237449 [TBL] [Abstract][Full Text] [Related]
12. CSN6 promotes malignant progression of oral squamous cell carcinoma by down-regulating TIMP-2. Gao WY; Yang G; Wang J; He JM; Wang P Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5419-5428. PubMed ID: 32495877 [TBL] [Abstract][Full Text] [Related]
13. CSN6-TRIM21 axis instigates cancer stemness during tumorigenesis. Qin B; Zou S; Li K; Wang H; Wei W; Zhang B; Xiao L; Choi HH; Tang Q; Huang D; Liu Q; Pan Q; Meng M; Fang L; Lee MH Br J Cancer; 2020 May; 122(11):1673-1685. PubMed ID: 32225170 [TBL] [Abstract][Full Text] [Related]
14. CUL4A regulates endometrial cancer cell proliferation, invasion and migration by interacting with CSN6. Wang X; Chen T Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179082 [TBL] [Abstract][Full Text] [Related]
15. CSN6 drives carcinogenesis by positively regulating Myc stability. Chen J; Shin JH; Zhao R; Phan L; Wang H; Xue Y; Post SM; Ho Choi H; Chen JS; Wang E; Zhou Z; Tseng C; Gully C; Velazquez-Torres G; Fuentes-Mattei E; Yeung G; Qiao Y; Chou PC; Su CH; Hsieh YC; Hsu SL; Ohshiro K; Shaikenov T; Wang H; Yeung SC; Lee MH Nat Commun; 2014 Nov; 5():5384. PubMed ID: 25395170 [TBL] [Abstract][Full Text] [Related]
16. CSN6 aggravates Ang II-induced cardiomyocyte hypertrophy via inhibiting SIRT2. Mei ZL; Wang HB; Hu YH; Xiong L Exp Cell Res; 2020 Nov; 396(1):112245. PubMed ID: 32882218 [TBL] [Abstract][Full Text] [Related]
17. CSN6 promotes tumorigenesis of gastric cancer by ubiquitin-independent proteasomal degradation of p16 Du W; Liu Z; Zhu W; Li T; Zhu Z; Wei L; Song J; Pei D Cancer Biol Med; 2019 Aug; 16(3):514-529. PubMed ID: 31565481 [TBL] [Abstract][Full Text] [Related]
18. EGFR-ERK pathway regulates CSN6 to contribute to PD-L1 expression in glioblastoma. Su L; Guo W; Lou L; Nie S; Zhang Q; Liu Y; Chang Y; Zhang X; Li Y; Shen H Mol Carcinog; 2020 May; 59(5):520-532. PubMed ID: 32134157 [TBL] [Abstract][Full Text] [Related]
20. The prognostic value of CSN6 expression in upper tract urothelial carcinomas. Jhan JH; Lee YC; Li WM; Chang LL; Hsu WC; Lin HH; Liang PI; Hsu YL; Wu WJ; Lee HY; Li CC; Yeh HC; Ke HL Kaohsiung J Med Sci; 2019 Sep; 35(9):559-565. PubMed ID: 31339657 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]